Chemotherapy Use at the End of Life in Uganda
Purpose: Avoiding chemotherapy during the last 30 days of life has become a goal of cancer care in the United States and Europe, yet end-of-life chemotherapy administration remains a common practice worldwide. The purpose of this study was to determine the frequency of and factors predicting end-of-...
Main Authors: | Daniel Low, Emily C. Merkel, Manoj Menon, Gary H. Lyman, Henry Ddungu, Elizabeth Namukwaya, Mhoira Leng, Corey Casper |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2017-12-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.2016.007385 |
Similar Items
-
Comparison of the health-related quality of life of end stage kidney disease patients on hemodialysis and non-hemodialysis management in Uganda
by: Peace Bagasha, et al.
Published: (2021-04-01) -
Improving care for people with heart failure in Uganda: serial in-depth interviews with patients’ and their health care professionals
by: Elizabeth Namukwaya, et al.
Published: (2017-05-01) -
'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda.
by: Elizabeth Namukwaya, et al.
Published: (2017-01-01) -
Health-related quality of life, palliative care needs and 12-month survival among patients with end stage renal disease in Uganda: protocol for a mixed methods longitudinal study
by: Peace Bagasha, et al.
Published: (2020-12-01) -
Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute.
by: Manoj Menon, et al.
Published: (2018-01-01)